Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease
World Journal of Gastroenterology · 21.01.2024 · 30 (3) · 280-282
DOI: 10.3748/wjg.v30.i3.280 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 21.01.2024. Verfasst von Zi-Wen Meng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China. Hauptthemen laut MEDLINE: Curcumin, Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a nonspecific inflammatory disease of the intestine that includes Crohn’s disease and ulcerative colitis. Because IBD is difficult to heal and easily relapses, it could worsen patient quality of life and increase economic burdens. Curcumin (CUR) is a bioactive component derived from the rhizome of turmeric (Curcuma longa). Many basic and clinical studies have shown that CUR can efficiently treat IBD by decreasing the activity of proinflammatory cytokines by communicating with transcription factors and signaling molecules. However, due to the limitations of being almost insoluble in aqueous solutions and having low oral bioavailability, it is important to select appropriate pharmaceutical preparations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China.
- Department of Gastroenterology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
- Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com.
Zitieren
APA
Meng, Z. W., Chang, B., & Sang, L. X. (2024). Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. World Journal of Gastroenterology, 30(3), 280-282. https://doi.org/10.3748/wjg.v30.i3.280
Vancouver
Meng ZW, Chang B, Sang LX. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. World Journal of Gastroenterology. 2024;30(3):280-282. doi:10.3748/wjg.v30.i3.280
BibTeX
@article{Meng2024,
author = {Meng, Zi-Wen and Chang, Bing and Sang, Li-Xuan},
title = {Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease},
journal = {World Journal of Gastroenterology},
year = {2024},
volume = {30},
number = {3},
pages = {280--282},
doi = {10.3748/wjg.v30.i3.280}
}
EUVIMED